Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the pivotal Phase 3 TroFuse-005 trial evaluating sacituzumab tirumotecan (sac-TMT), an investigational ...
Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers through ...
BMW Group operates a sizeable Information Technology (IT) division in South Africa, which develops and maintains software for ...
Picking a JavaScript framework in 2026 is not the casual decision it was a decade ago. The framework you choose today will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results